203641 BMP-2, Human, Recombinant, E. coli

203641
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

Purity
≥95% by SDS-PAGE

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
203641-2UG
Retrieving availability...
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Plastic ampoule 2 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
      Catalogue Number203641
      Brand Family Calbiochem®
      SynonymsBone morphogenetic protein 2 precursor, BMP-2A
      References
      ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
      Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
      Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
      Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
      Morin, R., et al. 2006. Biomacromolecules 7, 131.
      Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
      Product Information
      FormLyophilized
      FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      BMP-2, Human, Recombinant, E. coli SDS

      Title

      Safety Data Sheet (SDS) 

      BMP-2, Human, Recombinant, E. coli Certificates of Analysis

      TitleLot Number
      203641

      References

      Reference overview
      Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
      Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
      Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
      Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
      Morin, R., et al. 2006. Biomacromolecules 7, 131.
      Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-May-2008 RFH
      SynonymsBone morphogenetic protein 2 precursor, BMP-2A
      DescriptionRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
      FormLyophilized
      FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
      Purity≥95% by SDS-PAGE
      SolubilityReconstitute to ≥100 µg/ml with 20 mM acetic acid containing 0.1% HSA or BSA. Further dilutions can be made in aqueous buffers just prior to use.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
      Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
      Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
      Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
      Morin, R., et al. 2006. Biomacromolecules 7, 131.
      Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.